Diana R Kerwin MD
Dementia
Director, Texas Alzheimer's and Memory, Presbyterian Hospital Assistant Professor, Department of Neurology and Neurotherapeutics, University of Texas Southwestern
Join to View Full Profile
8198 Walnut Hill LaneJackson 100Dallas, TX 75231
Phone+1 214-345-4449
Fax+1 214-345-1238
Dr. Kerwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1997 - 1999
Loyola University Medical CenterInternship, Internal Medicine, 1996 - 1997
Medical College of WisconsinClass of 1996
Certifications & Licensure
TX State Medical License 2013 - 2026
WI State Medical License 2002 - 2025
CA State Medical License 2018 - 2024
IL State Medical License 1999 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Geriatric Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
Clinical Trials
- Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease Start of enrollment: 2008 Sep 01
- Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Start of enrollment: 2015 Jul 01
- Flortaucipir PET Imaging in Subjects With FTD Start of enrollment: 2017 Apr 11
- Join now to see all
Publications & Presentations
PubMed
- Opportunities to encourage adoption of a biomarker-enabled care pathway for Alzheimer's in primary care.Soo Borson, Rhoda Au, Anna H Chodos, Sam Gandy, Holly Jain
Alzheimer's & Dementia. 2025-03-11 - 16 citationsThe Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Al...Richard C Mohs, Douglas Beauregard, John Dwyer, Jennifer Gaudioso, Jason Bork
Alzheimer's & Dementia. 2024-04-01 - 1 citationsRecruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD).Amanda N Szabo-Reed, Tristyn Hall, Eric D Vidoni, Angela Van Sciver, Monica Sewell
Alzheimer's & Dementia. 2023-10-14
Press Mentions
Alzheimer's Disease Treatment Offers Hope to Patients in the Early Stages of DiseaseAugust 19th, 2024- Frontotemporal Dementia: What You Need to Know About the Condition Affecting Bruce WillisMarch 6th, 2023
- What 42 Previously Unknown Genes May Tell Us About Treating Alzheimer’s DiseaseApril 25th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
